Search

Your search keyword '"Pavy, Stephan"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Pavy, Stephan" Remove constraint Author: "Pavy, Stephan"
43 results on '"Pavy, Stephan"'

Search Results

1. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

2. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

3. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

4. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

8. The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis

9. Improving agreement in assessment of synovitis in rheumatoid arthritis

11. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

12. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

17. Tumour necrosis factor (alpha) - 308G (arrow right) a polymorphism is not associated with response to TNF(alpha) blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis

22. Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy.

25. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort

26. Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection.

27. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort

32. Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

33. Imaging for the diagnosis and follow-up of ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinion

34. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinion

35. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

36. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

37. Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

39. Systemic sclerosis and gastric MALT lymphoma

41. Safety of Infliximab Used in Combination with Leflunomide or Azathioprine in Daily Clinical Practice

42. Establishment of the Minimum Clinically Important Difference for the Bath Ankylosing Spondylitis Indices: A Prospective Study

43. Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources